Intellegens

About:

Applied machine learning to accelerate innovation in materials, chemicals, manufacturing, and beyond.

Website: http://intellegens.com

Twitter/X: intellegensai

Top Investors: Innovate UK, Aerospace Xelerated

Description:

Intellegens applies machine learning to accelerate innovation for materials, chemicals, manufacturing, and beyond. Extract more value from real-world, sparse, noisy data. Win with optimised formulations, products, and processes. Save time and cost with up to 90% fewer experiments. We enable you to deploy advanced deep learning for maximum impact. Intellegens' Alchemite™ software, first developed at the University of Cambridge, trains deep neural networks from sparse, noisy data, where most machine learning approaches fail. Scientists, engineers, and analysts apply Alchemite™ through a simple web browser user interface, with powerful graphical analysis tools. Data science teams can integrate the Alchemite™ algorithm with their own tools, scripts, and workflows. This flexibility overcomes the challenges of deploying machine learning in real business and research environments. Successful applications included materials development, additive manufacturing, drug discovery, chemistry, manufacturing processes, plastics, and formulated products. Visit intellegens.ai for more information.

Total Funding Amount:

1.6M GBP

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Cambridgeshire, United Kingdom

Founded Date:

2017-01-01

Contact Email:

ben(AT)intellegens.com

Founders:

Ben Pellegrini

Number of Employees:

11-50

Last Funding Date:

2023-08-22

IPO Status:

Private

Industries:

© 2025 bioDAO.ai